Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 February 2002

Application of perfluorocarbon liquid in the removal of metallic intraretinal foreign bodies.

Armen H Vartanyan, Tadevos A Hovhannisyan

Med Sci Monit 2002; 8(2): CR66-71 :: ID: 420939


BACKGROUND: Virectomy is recognized as one of the best effective methodsfor removing interetinal foreign bodies, but many authors showed complications during or after removingIOFB. The purpose of our study was to show that the use of perfluorocarbon liquid minimizes complicationsduring pars plana vitrectomy for the removal of metallic intraretinal foreign bodies (IRFBs). MATERIAL/METHODS:Fourteen consecutive eyes presenting with penetrating eye injury and intraretinal foreign bodies hadpreviously undergone vitrectomy with injection of perfluorocarbon liquids and removal of IRFBs. In allcases a silicon oil or gas C3F8 tamponade was performed. In one case the removal of the foreign bodywas combined with repair of retinal detachment using internal tamponade with silicon oil. RESULTS: Aftera mean follow-up of 16.4 months, 78.5% of the eyes had recovered better than 20/70 vision, and 92.8%had attached retina. One patient had endophthalmitis and phthisis, and perioperative complications wereencountered in two cases. In one case there was a limited hemorrhage, intraretinal, while the other complicationwas a retinal detachment, which was immediately corrected. In the follow-up period endophthalmitis andlens opacity was found in one patient and epiretinal membrane in another case. These postoperative complicationswere repaired by additional surgery. CONCLUSIONS: The usage of perfluorocarbon liquid is effective forremoval of intraretinal foreign bodies, and allows to minimize intraoperative complications.

Keywords: Eye Injuries, Penetrating, Fluorocarbons, Foreign Bodies, Metals

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750